2Diamond TH,Stiel D,Lunzer M,et al.Hepatic osteodystrophy.Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease.Gastroenterology,1989,96:213-221
3Heaney RP.The bone-remodeling transient:implications for the interpretation of clinical studies of bone mass change.J Bone Miner Res,1994,9:1515-1523
4McCaughan GW,Feller RB.Osteoporosis in chronic liver disease:pathogenesis,risk factors,and management.Dig Dis,1994,12:223-231
5Eriksen EF,Kassem M,Langdahl B.Growth hormone,insulin-like growth factors and bone remodeling.Eur J Clin Invest,1996,26:525-534
6Cemborain A,Castilla-Cortazar I,Garcia M,et al.Osteopenia in rats with liver cirrhosis:beneficial effects of IGF-I treatment.J Hepatol,1998,28:122-131
7Gallego-Rojo FJ,Gonzalez-Calvin JL,Munoz-Torres M,et al.Bone mineral density,serum insulin-like growth factor I,and bone turnover markers in viral cirrhosis.Hepatology,1998,28:695-699
8Rosen CJ.IGF-I and osteoporosis.Clin Lab Med,2000,20(3):591-602
9Janes CH,Dickson ER,Okazaki R,et al.Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice.J Clin Invest,1995,95:2581-2586
10Bell H,Raknerud N,Falch JA,et al.Inappropriately low levels of gonadotrophins in amenorrhoeic women with alcoholic and non-alcoholic cirrhosis.Eur J Endocrinol,1995,132:444-449
